Basic Materials / Specialty ChemicalsBSE
$39.46
-2.31 (-5.53%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-17.3M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
40/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$954M
P/E
21.6x
↑EV/EBITDA
7.9x
↓ROE
5.8%
↑Gross Margin
23.9%
↑Debt/Equity
0.37
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-10.7%
FCF CAGR
—
FCF margin
-4.9%
FCF / Net income
-0.93x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $981.2M · net income $52.0M · FCF $-48.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $981.2M | $981.2M | $1.05B | $1.20B | $1.38B |
| Net Income | $52.0M | $52.0M | $71.4M | $94.4M | $111.1M |
| EBITDA | $163.5M | $163.5M | $146.1M | $175.9M | $200.2M |
| EPS | 2.15 | 2.15 | 3.04 | 4.10 | 4.82 |
| Gross Margin | 23.9% | 23.9% | 18.9% | 19.1% | 19.9% |
| Operating Margin | 8.0% | 8.0% | 8.5% | 11.3% | 12.1% |
| Net Margin | 5.3% | 5.3% | 6.8% | 7.8% | 8.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.37 | 0.37 | 0.42 | 0.76 | 0.82 |
| Current Ratio | 2.90 | 2.90 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-48.4M | $-48.4M | $131.0M | $-17.3M | $-143.2M |
| Returns | |||||
| ROE | 5.8% | 5.8% | 8.4% | 14.0% | 19.2% |
| Valuation | |||||
| P/E | 21.56 | 21.56 | — | — | — |
| EV/EBITDA | 7.91 | 7.91 | — | — | — |
| P/B | 1.06 | 1.06 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | -6.7% | -6.7% | -12.6% | -12.6% | — |
| EPS Growth | -29.2% | -29.2% | -25.9% | -14.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
17.6%
EPS terminal req.
$3.50
Spread vs growth
-46.9%
5Y implied EPS CAGR
14.5%
EPS terminal req.
$4.24
Spread vs growth
-43.8%
10Y implied EPS CAGR
12.2%
EPS terminal req.
$6.82
Spread vs growth
-41.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-25.2%
Start / end P/E
17.4x → 18.4x
EPS bridge
3.04 → 2.15
Residual
-1.7%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.